KUALA LUMPUR, Sept 10 — Nearly half of people fully vaccinated against Covid-19 in Malaysia received Sinovac at about 49 per cent, followed by Pfizer-BioNTech at about 43 per cent as of yesterday.
About 6 per cent of people fully inoculated in Malaysia received the AstraZeneca-Oxford jab, while just 0.25 per cent received CanSino, a single-shot vaccine.
Sarawak has the largest population coverage in Malaysia using Sinovac at 77.7 per cent, where some 1.4 million people were fully inoculated with the Chinese vaccine, followed by 336,737 people double-jabbed with Pfizer at 18.7 per cent.
Pfizer-BioNtech’s vaccine by the American-German partnership of Pfizer and BioNTech was most widely used in terms of population coverage in the island of Labuan, covering 88.8 per cent of its fully vaccinated individuals. Only about 9 per cent of fully inoculated individuals in Labuan received Sinovac. AstraZeneca and CanSino have not yet been administered in Labuan.
Chinese jab CanSino has so far only been administered in Sabah, Kelantan and Perak, comprising just 0.25 per cent of the total fully vaccinated Malaysia population.
Majority Sinovac: Sarawak, Selangor, Terengganu, KL
Other than Sarawak, Sinovac was more commonly used in Selangor, comprising about 58.7 per cent of fully vaccinated individuals, followed by Terengganu (54.3 per cent), and Kuala Lumpur (53 per cent).
The capital city received the biggest proportion of AstraZeneca in terms of population coverage, with about 24 per cent of its fully vaccinated residents getting the UK shot.
Majority Pfizer: Labuan, Perlis, Sabah, Pahang, Negeri Sembilan, Kelantan, Kedah, Putrajaya
Perlis has the second highest Pfizer vaccine coverage after Labuan, with 69.09 per cent of its fully vaccinated individuals receiving the mRNA vaccine. Only about 29 per cent of fully inoculated residents in Perlis received Sinovac.
About 65.4 per cent of fully inoculated people in Sabah received Pfizer, followed by Pahang (64.7 per cent) that has double-jabbed 428,305 people with Pfizer.
In Negeri Sembilan, 65 per cent of its fully vaccinated residents were protected with Pfizer, followed by Sinovac at about 34 per cent.
Kelantan and Kedah have about 63.6 per cent and 60.8 per cent of their fully vaccinated residents jabbed with Pfizer respectively.
Putrajaya — which does not have fully vaccinated individuals receiving the UK’s AstraZeneca-Oxford jab along with Labuan — has slightly more people getting Pfizer at about 55 per cent versus Sinovac’s 45 per cent.
Roughly Equal: Melaka And Perak, More Than 5% AstraZeneca In Penang And Johor
Penang had the second highest population coverage of fully vaccinated individuals administered with AstraZeneca after Kuala Lumpur. About 8.57 per cent of fully vaccinated people in the island were protected with AstraZeneca, while about 50 per cent received Pfizer and 40.4 per cent got Sinovac.
In Johor, about 52 per cent of fully vaccinated individuals received Pfizer, followed by Sinovac (42 per cent) and AstraZeneca (5 per cent).
Melaka and Perak have a relatively balanced distribution of Pfizer and Sinovac among their fully vaccinated individuals, with the mRNA vaccine coverage slightly exceeding Sinovac.
CodeBlue’s analysis used data provided by the Covid-19 Immunisation Task Force (CITF) on GitHub. The percentages do not add up to 100 per cent, according to CITF on GitHub, because of pending data involving doses “quarantined” in the vaccine management system due to temporary errors or inconsistencies in vaccine barcode, batch number etc.
